Ming Liu has been a key statistical programming leader of Brightech International (Brightech) since 2017. He has over 28 years of experience in statistical programming, biostatistics, and data & computational sciences. Ming has contributed significantly to Brightech’s success over his 6-year tenure and has advanced to his current position as the Executive Director of Statistical Programming of the organization. Brightech was a CRO with a strong niche in biostatistics and statistical programming services and was acquired by Everest in December 2022. 

Ming is a seasoned Statistical Programmer with a strong statistical and data sciences background and experience, and he is a proven leader in clinical trial statistical programming. Ming provides executive oversight in Everest’s global Statistical Programming operations and works closely with his direct reports and teams located in USA, Taiwan, and China. Mings strengths include his project portfolio management close interfacing with clients and maintaining strong client relationships. In his efforts to support clinical research programs, Ming’s work has exposed him to most therapeutic areas, with focused, solid expertise in endocrinology and autoimmune.

In Ming’s pharmaceutical clinical research career before joining Brightech, he worked for The Medicines Company, Renegeron Pharmaceuticals, Genta, Forest Laboratories, and others.

Ming earned his M.Sc. degree in Statistics from The Bernard M. Baruch College, New York, New York. He also holds a B.Sc. degree in Statistics from Fudan University, Shanghai, China.